Wiersinga W M, Touber J L, Trip M D, van Royen E A
J Clin Endocrinol Metab. 1986 Aug;63(2):485-91. doi: 10.1210/jcem-63-2-485.
Iodine excess is associated with a low thyroidal radioiodine uptake due to dilution of the radioisotope by the increased stable iodide pool. We studied thyroidal uptake of radioisotopes in cardiac patients with iodine excess due to amiodarone treatment. 99mTc-pertechnetate scintigraphy was performed in 13 patients receiving long term amiodarone therapy. Five patients had a clearly visible thyroid gland, and 8 patients had no or a very faint thyroid image. All patients with positive scans had an increased plasma TSH level, whereas all patients with negative scans had a normal or absent TSH response to TRH. Thyroidal uptake and discharge of 123I were studied in 30 other patients. Group I (n = 11) had normal plasma TSH responses to TRH and no iodine excess, group II (n = 7) had normal TSH responses to TRH and excess iodine from metrizoate angiography in the previous month, group III (n = 7) had normal or decreased TSH responses to TRH while receiving long term amiodarone therapy, and group IV (n = 5) had increased TSH responses to TRH while receiving long term amiodarone therapy. The mean radioiodine uptake value in group I [5.4 +/- 0.8% (+/- SE) at 60 min] was higher than those in group II (2.3 +/- 0.7%; P = 0.009) and group III (0.8 +/- 0.3%; P = 0.0005), but not different from that in group IV (5.3 +/- 1.2%; P = NS). Radioiodine discharge after perchlorate (expressed as a percentage of the 60 min uptake) in group I (10.1 +/- 2.2%) was lower than those in group II (24.9 +/- 10.6%; P = 0.05) and group III (28.8 +/- 5.3%; P less than 0.005), whereas discharge in group IV (58.0 +/- 6.1%) was greater than those in group II (P less than 0.05) and group III (P less than 0.01). In conclusion, 1) thyroid visualization by 99mTc-pertechnetate and thyroid radioiodine uptake during iodine excess are decreased in euthyroid and hyperthyroid patients, but preserved in hypothyroid patients. 2) The organification defect induced by iodine excess is greater in iodide-induced hypothyroidism than in eu- or hyperthyroidism. These findings may be explained by the increased TSH secretion in hypothyroidism and/or by decreased thyroidal concentration of an unknown specific iodinated compound (whose concentration and action vary with the total organic iodine content of the thyroid) that mediates the inhibition of iodide transport.
碘过量与甲状腺放射性碘摄取降低有关,这是由于增加的稳定碘池对放射性同位素产生了稀释作用。我们研究了因胺碘酮治疗导致碘过量的心脏病患者的甲状腺对放射性同位素的摄取情况。对13例接受长期胺碘酮治疗的患者进行了99mTc-高锝酸盐闪烁扫描。5例患者甲状腺清晰可见,8例患者甲状腺影像不明显或非常模糊。所有扫描阳性的患者血浆促甲状腺激素(TSH)水平升高,而所有扫描阴性的患者对促甲状腺激素释放激素(TRH)的TSH反应正常或无反应。对另外30例患者研究了123I的甲状腺摄取和释放情况。第一组(n = 11)对TRH的血浆TSH反应正常且无碘过量,第二组(n = 7)对TRH的TSH反应正常且前一个月因泛影葡胺血管造影存在碘过量,第三组(n = 7)在接受长期胺碘酮治疗时对TRH的TSH反应正常或降低,第四组(n = 5)在接受长期胺碘酮治疗时对TRH的TSH反应增强。第一组在60分钟时的平均放射性碘摄取值[5.4 +/- 0.8%(+/-标准误)]高于第二组(2.3 +/- 0.7%;P = 0.009)和第三组(0.8 +/- 0.3%;P = 0.0005),但与第四组(5.3 +/- 1.2%;P = 无显著性差异)无差异。第一组服用高氯酸盐后的放射性碘释放(以60分钟摄取量的百分比表示)为(10.1 +/- 2.2%)低于第二组(24.9 +/- 10.6%;P = 0.05)和第三组(28.8 +/- 5.3%;P < 0.005),而第四组的释放(58.0 +/- 6.1%)大于第二组(P < 0.05)和第三组(P < 0.01)。总之,1)在甲状腺功能正常和甲状腺功能亢进的患者中,碘过量时99mTc-高锝酸盐的甲状腺显影和甲状腺放射性碘摄取降低,但在甲状腺功能减退的患者中保持正常。2)碘过量引起的有机化缺陷在碘化物诱导的甲状腺功能减退中比在甲状腺功能正常或亢进时更明显。这些发现可能是由于甲状腺功能减退时TSH分泌增加和/或一种未知的特定碘化化合物(其浓度和作用随甲状腺总有机碘含量而变化)的甲状腺浓度降低,该化合物介导碘化物转运的抑制。